InvestorsHub Logo
Replies to #15597 on FDA Plays
icon url

Trade_zecco

04/11/11 2:45 PM

#15621 RE: pcrutch #15597

Hey man..what's your view on PCRX ?? they have PDUFA date of 7/28

Thanks,
TZ
icon url

gym gravity

05/31/11 10:42 AM

#18805 RE: pcrutch #15597

I have been in CORT for 4 years... made coin back on the run to 6 and added back along the way. chart looks like it is going to be anticipated. Endocrinology conference june 4, oral session:

Presentation details are as follows:

Abstract title: Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Refractory Cushing's Syndrome: Results from the Study of the Efficacy and Safety of Mifepristone in the Treatment of Endogenous Cushing's Syndrome (SEISMIC).
Abstract #: OR09-5
Presenter: Maria Fleseriu, M.D., F.A.C.E.
Oral Session Title: CLINICAL -- Will Medical Management Replace Surgery for Cushing Syndrome?
Date: Saturday, June 4, 2011
Presentation Time: 12:15 pm EDT
Room: 153ABC

http://finance.yahoo.com/news/Corcept-Therapeutics-to-iw-1734753088.html?x=0&.v=1